ライフサイエンスコーパス: allocation concealment

1 ation (by age, primary cancer, and sex) with allocation concealment.

2 misation (by age, sex, and cancer type) with allocation concealment.

3 d on the adequacy of sequence generation and allocation concealment.

4 using a random-number table with centralized allocation concealment.

5 ion was computer-generated, with centralized allocation concealment.

6 and only 13% of the trials clearly explained allocation concealment.

7 Proper randomisation rests on adequate allocation concealment.

8 ny medical researchers confuse blinding with allocation concealment.

9 selection and confounding biases with proper allocation concealment.

10 ist was used within each stratum to preserve allocation concealment.

11 ian with a minimisation program, maintaining allocation concealment.

12 inding (15%), sequence generation (23%), and allocation concealment (17%); and details about actual d

13 ion (45%), random sequence generation (43%), allocation concealment (45%), and blinding (37%).

14 by the Jadad score, the use of an effective allocation concealment (AC) and the existence of an inte

15 Two authors extracted data on allocation concealment, allocation sequence, blinding, c

16 Two authors independently extracted data on allocation concealment, allocation sequence, blinding, c

17 Only 1 study described adequate allocation concealment and 2 reported an intent-to-treat

18 esponse with lower trial quality (suboptimal allocation concealment and blinding), use of condiments,

19 ias criteria (e.g., randomization, blinding, allocation concealment) and other study design features

20 timates and adequacy of sequence generation, allocation concealment, and baseline comparability among

21 tems of selection bias (sequence generation, allocation concealment, and baseline comparability) in t

22 The majority of studies had inadequate allocation concealment, and few were analysed according

23 fferent glucosamine preparations, inadequate allocation concealment, and industry bias.

24 es of reports of random sequence generation, allocation concealment, and intent-to-treat analyses wer

25 uacy of reported random sequence generation, allocation concealment, blinding, and analysis.

26 ibed an appropriate method of randomization, allocation concealment, blinding, and completeness of fo

27 re considered high quality if randomization, allocation concealment, blinding, and follow-up complete

28 tected sexual intercourse to treatment, with allocation concealment by identical opaque boxes labelle

29 95% CI: 0.01 to 0.25) and inadequate/unknown allocation concealment (difference in ES = 0.15; 95% CI:

30 nce was lowered due to unclear reporting for allocation concealment, dropouts, missing data on outcom

31 Proper allocation concealment frequently frustrates clinical in

32 appropriate sequence generation and adequate allocation concealment from January 1, 2009, to March 31

33 wever, methodologic problems such as lack of allocation concealment, inadequate random sequence gener

34 s was assessed under masked conditions using allocation concealment, Jadad score, and a CONSORT check

35 Indeed, inadequate allocation concealment leads to exaggerated estimates of

36 lity varied, with uncertainty about adequate allocation concealment methods in eight trials and lack

37 Except for allocation concealment, no feature of study design expla

38 graded based on the risk of bias (scored on allocation, concealment of intervention, incomplete data

39 ates of reported random sequence generation, allocation concealment, power, and intent-to-treat analy

40 ethodologic quality were blinding, method of allocation concealment, presence of mortality as a study

41 An allocation concealment process keeps clinicians and part

42 nd with inadequate or unclear (vs. adequate) allocation concealment (ratio of odds ratios, 0.93 [CrI,

43 n sequence generation and inadequate/unknown allocation concealment, respectively.

44 120 women were randomly assigned, using allocation concealment, to receive 4 mg zoledronic acid

45 Allocation concealment was achieved using a web-based sy

46 Treatment allocation concealment was adequate in 9 studies; 16 wer

47 (n = 20) of nonsurgical trials, and adequate allocation concealment was recorded in 46% (n = 30) and

48 Allocation concealment was unclear in the majority of tr

49 ised, adequate methods for randomization and allocation concealment were found in 17% and 7% of studi